NVAX – Novavax, Inc.
Novavax, Inc.NVAX
$6.00Name : Novavax, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $965,064,000.00
EPSttm : -1.23
Novavax, Inc.
$6.00
3.23%$0.2Float Short %
25.16
Margin Of Safety %
Put/Call OI Ratio
0.61
EPS Next Q Diff
1.03
EPS Last/This Y
1.72
EPS This/Next Y
-0.16
Price
6
Target Price
16.14
Analyst Recom
2.14
Performance Q
-29.66
Relative Volume
1.03
Beta
3.13
Ticker: NVAX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | NVAX | 7.72 | 0.61 | 0.12 | 247924 |
| 2025-03-21 | NVAX | 7.61 | 0.61 | 0.33 | 249339 |
| 2025-03-24 | NVAX | 7.68 | 0.62 | 0.23 | 234680 |
| 2025-03-25 | NVAX | 7.57 | 0.61 | 0.10 | 242635 |
| 2025-03-26 | NVAX | 7.39 | 0.60 | 0.20 | 244445 |
| 2025-03-27 | NVAX | 7.25 | 0.59 | 0.86 | 247289 |
| 2025-03-28 | NVAX | 7 | 0.58 | 0.37 | 248319 |
| 2025-03-31 | NVAX | 6.41 | 0.59 | 0.37 | 241908 |
| 2025-04-01 | NVAX | 6 | 0.59 | 0.52 | 250289 |
| 2025-04-02 | NVAX | 5.98 | 0.58 | 1.52 | 257593 |
| 2025-04-03 | NVAX | 5.59 | 0.60 | 0.48 | 263661 |
| 2025-04-04 | NVAX | 6.23 | 0.58 | 0.29 | 267199 |
| 2025-04-07 | NVAX | 6.54 | 0.59 | 0.23 | 264074 |
| 2025-04-08 | NVAX | 6.32 | 0.60 | 0.13 | 266286 |
| 2025-04-09 | NVAX | 6.76 | 0.59 | 0.07 | 269351 |
| 2025-04-10 | NVAX | 5.43 | 0.59 | 0.25 | 270274 |
| 2025-04-11 | NVAX | 5.84 | 0.57 | 0.30 | 276599 |
| 2025-04-14 | NVAX | 6.41 | 0.57 | 0.07 | 264064 |
| 2025-04-15 | NVAX | 6.39 | 0.56 | 0.25 | 267328 |
| 2025-04-16 | NVAX | 6.2 | 0.56 | 1.90 | 269234 |
| 2025-04-17 | NVAX | 6.01 | 0.61 | 2.19 | 287934 |
| 2025-04-18 | NVAX | 6 | 0.61 | 1.89 | 287934 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | NVAX | 7.72 | 50.5 | - | -0.24 |
| 2025-03-21 | NVAX | 7.61 | 50.5 | - | -0.24 |
| 2025-03-24 | NVAX | 7.69 | 50.5 | - | -0.24 |
| 2025-03-25 | NVAX | 7.56 | 50.5 | - | -0.24 |
| 2025-03-26 | NVAX | 7.39 | 50.5 | - | -0.24 |
| 2025-03-27 | NVAX | 7.26 | 50.5 | - | -0.24 |
| 2025-03-28 | NVAX | 7.00 | 50.5 | - | -0.24 |
| 2025-03-31 | NVAX | 6.41 | 50.5 | - | -0.24 |
| 2025-04-01 | NVAX | 6.00 | 50.5 | - | -0.24 |
| 2025-04-02 | NVAX | 5.98 | 50.5 | - | -0.24 |
| 2025-04-03 | NVAX | 5.60 | 50.5 | - | -0.24 |
| 2025-04-04 | NVAX | 6.24 | 50.5 | - | -0.24 |
| 2025-04-07 | NVAX | 6.53 | 151.8 | - | 0.27 |
| 2025-04-08 | NVAX | 6.31 | 151.8 | - | 0.27 |
| 2025-04-09 | NVAX | 6.75 | 151.8 | - | 0.27 |
| 2025-04-10 | NVAX | 5.43 | 151.8 | - | 0.27 |
| 2025-04-11 | NVAX | 5.86 | 151.8 | - | 0.27 |
| 2025-04-14 | NVAX | 6.41 | 151.8 | - | 0.27 |
| 2025-04-15 | NVAX | 6.39 | 151.8 | - | 0.27 |
| 2025-04-16 | NVAX | 6.21 | 151.8 | - | 0.27 |
| 2025-04-17 | NVAX | 6.00 | 151.8 | - | 0.27 |
| 2025-04-18 | NVAX | 6.00 | 151.8 | - | 0.49 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | NVAX | -0.10 | 1.97 | 26.76 |
| 2025-03-21 | NVAX | -0.10 | 1.97 | 26.76 |
| 2025-03-24 | NVAX | -0.10 | 1.96 | 26.76 |
| 2025-03-25 | NVAX | -0.10 | 1.96 | 26.76 |
| 2025-03-26 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-03-27 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-03-28 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-03-31 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-04-01 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-04-02 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-04-03 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-04-04 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-04-07 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-04-08 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-04-09 | NVAX | -0.10 | 1.96 | 25.62 |
| 2025-04-10 | NVAX | -0.10 | 1.96 | 25.16 |
| 2025-04-11 | NVAX | -0.10 | 1.96 | 25.16 |
| 2025-04-14 | NVAX | -0.10 | 1.96 | 25.16 |
| 2025-04-15 | NVAX | -0.10 | 1.96 | 25.16 |
| 2025-04-16 | NVAX | -0.10 | 1.96 | 25.16 |
| 2025-04-17 | NVAX | -0.10 | 1.96 | 25.16 |
| 2025-04-18 | NVAX | -0.10 | 1.96 | 25.16 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.83
Avg. EPS Est. Current Quarter
-0.42
Avg. EPS Est. Next Quarter
0.2
Insider Transactions
-0.1
Institutional Transactions
1.96
Beta
3.13
Average Sales Estimate Current Quarter
67
Average Sales Estimate Next Quarter
155
Fair Value
Quality Score
68
Growth Score
35
Sentiment Score
77
Actual DrawDown %
98.2
Max Drawdown 5-Year %
-98.8
Target Price
16.14
P/E
Forward P/E
17.14
PEG
P/S
1.41
P/B
P/Free Cash Flow
EPS
-1.32
Average EPS Est. Cur. Y
0.49
EPS Next Y. (Est.)
0.33
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-27.49
Relative Volume
1.03
Return on Equity vs Sector %
10.1
Return on Equity vs Industry %
23.5
EPS 1 7Days Diff
0.7
EPS 1 30Days Diff
0.74
EBIT Estimation
Novavax, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 952
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
stock quote shares NVAX – Novavax, Inc. Stock Price stock today
news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NVAX – Novavax, Inc. yahoo finance google finance
stock history NVAX – Novavax, Inc. invest stock market
stock prices NVAX premarket after hours
ticker NVAX fair value insiders trading